The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis.

Zhang, Lei

The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis. [electronic resource] - Laboratory investigation; a journal of technical methods and pathology Aug 2014 - 839-50 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1530-0307

10.1038/labinvest.2014.69 doi


Aldosterone--chemistry
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Animals
Anti-Inflammatory Agents--therapeutic use
Cilazapril--therapeutic use
Dialysis Solutions--chemistry
Disease Models, Animal
Drug Therapy, Combination
Lymphocytes--drug effects
Macrophages--drug effects
Male
Mineralocorticoid Receptor Antagonists--therapeutic use
Peritoneal Dialysis, Continuous Ambulatory--adverse effects
Peritoneal Fibrosis--etiology
Peritoneum--drug effects
Peritonitis--etiology
Random Allocation
Rats
Rats, Wistar
Receptors, Mineralocorticoid--chemistry
Spironolactone--therapeutic use
Transforming Growth Factor beta1--analysis